We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Molecular Manipulation Induces Skin Cells to Produce Hair

By LabMedica International staff writers
Posted on 22 Aug 2017
Working with mouse skin cells, researchers have generated hair-producing follicles from newborn and adult cells and traced the molecular pathways that control their development.

Investigators at the University of Southern California (Los Angeles, USA) were particularly interested in determining whether adult skin cells could be transformed into hair-producing follicles. More...
Towards this end, they began with an in depth imaging analysis of skin cells from newborn mice during the process of forming three-dimensional, hair-producing organoids.

Observations described in the August 10, 2017, online edition of the journal Proceedings of the [U.S.] National Academy of Sciences revealed that skin cells from newborn mice formed organoids by transitioning through six distinct phases: 1) dissociated cells; 2) aggregated cells; 3) cysts; 4) coalesced cysts; 5) layered skin; and 6) skin with follicles, which robustly produced hair after being transplanted onto the back of a host mouse. These physical manifestations were driven at the molecular level by the sequential expression of adhesion molecules, growth factors, Wnt signaling proteins, and matrix metalloproteinases (MMPs).

In contrast, skin cells from adult mice formed small aggregates, but then development stalled when grown in vitro cultures. Findings from the newborn cells study enabled the investigators to develop a strategy to restore morphological transitions and rescue the hair-forming ability of adult organoids: (i) continuous PKC (Protein kinase C) inhibition and (ii) timely supply of the growth factors IGF (Insulin-like growth factor) and VEGF (Vascular endothelial growth factor), Wnts, and MMPs.

By providing the correct molecular and genetic cues in the proper sequence, the investigators were able to stimulate adult organoids to continue their development and eventually produce hair. Ultimately, adult organoids produced about 40% as much hair as the newborn organoids.

"Normally, many aging individuals do not grow hair well, because adult cells gradually lose their regenerative ability," said senior author Dr. Cheng-Ming Chuong, professor of pathology at the University of Southern California. "With our new findings, we are able to make adult mouse cells produce hair again. In the future, this work can inspire a strategy for stimulating hair growth in patients with conditions ranging from alopecia to baldness."

Related Links:
University of Southern California


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Blood Ammonia Test Analyzer
DRI-CHEM NX10N
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.